Genmab A/S (GMAB)
34.35
+1.33
(+4.03%)
USD |
NASDAQ |
Aug 25, 16:00
34.35
0.00 (0.00%)
After-Hours: 19:59
Genmab Price : 34.35 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 32.82 | 33.32 | 32.74 | 33.02 | 3.247M |
| Aug 21, 2026 | 33.36 | 33.98 | 33.28 | 33.45 | 2.535M |
| Aug 20, 2026 | 33.60 | 33.77 | 33.20 | 33.41 | 6.348M |
| Aug 19, 2026 | 33.41 | 34.18 | 33.26 | 34.11 | 3.229M |
| Aug 18, 2026 | 32.86 | 33.11 | 32.66 | 32.96 | 2.707M |
| Aug 17, 2026 | 32.31 | 32.94 | 32.28 | 32.84 | 3.432M |
| Aug 14, 2026 | 31.31 | 31.98 | 31.14 | 31.94 | 3.427M |
| Aug 13, 2026 | 31.50 | 31.55 | 30.98 | 31.34 | 4.095M |
| Aug 12, 2026 | 30.69 | 31.61 | 30.69 | 31.42 | 3.517M |
| Aug 11, 2026 | 30.91 | 30.98 | 30.52 | 30.85 | 1.587M |
| Aug 10, 2026 | 30.63 | 31.01 | 30.55 | 30.87 | 2.800M |
| Aug 07, 2026 | 31.44 | 31.79 | 30.92 | 31.25 | 3.507M |
| Aug 06, 2026 | 29.50 | 29.86 | 28.47 | 29.83 | 5.234M |
| Aug 05, 2026 | 29.46 | 29.77 | 29.21 | 29.26 | 1.404M |
| Aug 04, 2026 | 29.24 | 29.32 | 28.94 | 29.02 | 1.321M |
| Aug 03, 2026 | 28.64 | 28.72 | 28.09 | 28.68 | 1.740M |
| Jul 31, 2026 | 28.51 | 28.92 | 28.23 | 28.87 | 2.135M |
| Jul 30, 2026 | 28.12 | 28.67 | 28.03 | 28.64 | 1.666M |
| Jul 29, 2026 | 28.87 | 28.94 | 28.43 | 28.52 | 1.161M |
| Jul 28, 2026 | 29.02 | 29.38 | 28.91 | 29.00 | 2.213M |
| Jul 27, 2026 | 28.77 | 29.15 | 28.56 | 28.80 | 1.527M |
| Jul 24, 2026 | 29.06 | 29.11 | 28.57 | 28.87 | 1.676M |
| Jul 23, 2026 | 28.51 | 29.20 | 28.33 | 29.17 | 1.135M |
| Jul 22, 2026 | 29.26 | 29.32 | 28.83 | 28.85 | 1.853M |
| Jul 21, 2026 | 28.05 | 28.55 | 27.98 | 28.36 | 871699.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| AbbVie, Inc. | 265.81 |
| Ascendis Pharma A/S | 253.38 |
| Zealand Pharma A/S | 48.24 |
| Bavarian Nordic A/S | 11.04 |
| Evaxion AS | 3.39 |
Price Related Metrics
| PE Ratio | 27.20 |
| PS Ratio | 5.304 |
| Price to Book Value | 3.443 |
| Price to Free Cash Flow | 25.19 |
| Earnings Yield | 3.68% |
| Market Cap | 20.51B |
| Operating PE Ratio | 16.43 |
| Normalized PE Ratio | 22.29 |